InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Mortimer Ian. Director active across 2 companies, notably Xenon Pharmaceuticals Inc.. Aggregated, 8 reports have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €560k. Activity tracked since 24 May 2023. The latest transaction was disclosed on 9 March 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
MORTIMER IAN is PRESIDENT & CEO at Xenon Pharmaceuticals Inc. (XNAS). He has 8 filings in total, and in the sampled recent filings the volumes are 0 EUR in buys and 559735 EUR in sells, between 2023-05-26 and 2026-03-13. The most common transaction nature is Option exercise.